Article Text

Download PDFPDF

Impact of COVID-19 infection rates on admissions for ambulatory care sensitive conditions: nationwide difference-in-difference design in Japan
  1. Makoto Kaneko1,
  2. Sayuri Shimizu1,
  3. Ai Oishi1 and
  4. Kiyohide Fushimi2
  1. 1Department of Health Data Science, Yokohama City University, Yokohama, Kanagawa, Japan
  2. 2Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Bunkyo-ku, Tokyo, Japan
  1. Correspondence to Dr Makoto Kaneko; kanekom{at}yokohama-cu.ac.jp

Abstract

Objectives SARS-CoV-2 infection (COVID-19) has affected tertiary medical institutions and primary care. Admission for ambulatory care sensitive conditions (ACSCs) is an important indicator of primary care quality. However, no nationwide study, especially in Asia, has examined the association between admissions for ACSCs and local surges in COVID-19. This study aimed to examine how the number of admissions for ACSCs has changed in Japan between the areas with higher and lower rates of COVID-19 infection.

Design This was a retrospective two-stage cross-sectional study. We employed a difference-in-difference design to compare the number of hospital admissions for ACSCs between the areas with higher and lower rates of COVID-19 infection in Japan.

Setting The study used a nationwide database in Japan.

Participants All patients were aged 20 years and above and were admitted due to ACSCs during the study period between March and September 2019 (before the pandemic) and between March and September 2020 (during the pandemic).

Results The total number of ACSC admissions was 464 560 (276 530 in 2019 and 188 030 in 2020). The change in the number of admissions for ACSCs per 100 000 was not statistically significant between the areas with higher and lower rates of COVID-19 infection: 7.50 (95% CI −87.02 to 102.01). In addition, in acute, chronic and preventable ACSCs, the number of admissions per 100 000 individuals did not change significantly.

Conclusion Although admissions for ACSCs decreased during the COVID-19 pandemic, there was no significant change between the areas with higher and lower rates of COVID-19 infection. This implies that the COVID-19 pandemic affected the areas with higher infection rates and the areas with lower rates.

  • COVID-19
  • general practice
  • primary health care

Data availability statement

Data are available on reasonable request. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

WHAT IS ALREADY KNOWN ON THIS TOPIC

  • Although ambulatory care sensitive conditions (ACSCs) is an important quality indicator of primary care, there is no nationwide study, especially in Asia, examining the association between admission for ACSCs and COVID-19 infection.

WHAT THIS STUDY ADDS

  • This study revealed the number of hospital admissions for total and acute/chronic/preventable ACSCs before and during the COVID-19 pandemic in Japan. Although admissions for ACSCs decreased during the COVID-19 pandemic, there was no significant change between the areas with higher and lower rates of COVID-19 infection.

HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY

  • The clinical implications of the study are that COVID-19 affects the areas with higher infection rates and the areas with lower rates.

Introduction

SARS-CoV-2 infection (COVID-19) has spread worldwide at the end of 2019. The WHO declared a pandemic in March 2020.1 The high incidence of critically ill patients requiring intensive care during this period is associated with a significant burden on tertiary care facilities.2 3 COVID-19 has had an impact on primary care as well.4 For example, in the Netherlands, the pandemic has changed patient behaviour by increasing the number of hospital visits for respiratory symptoms and has decreased visits for chronic conditions and face-to-face consultations, while increasing the use of telemedicine.5

The pandemic hit Japan slightly later. The first case of COVID-19 was reported in January 2020.6 The state of emergency was declared in Hokkaido, which is the northern part of Japan.6 Subsequently, the state of emergency was declared in April.6 The total number of COVID- 19 infections in Japan exceeded 10 000 people.6

Avoidable hospital admissions (admissions for ambulatory care sensitive conditions (ACSCs)) are defined as hospitalisation that is avoidable if appropriate primary care is provided.7 8 Admissions for ACSCs have been employed as a quality indicator to assess primary care outcomes.9 10 Even under the COVID-19 pandemic, offering care for chronic diseases and prevention is an important aspect of primary care,5 and appropriate control of admissions for ACSCs is essential to reduce the burden on secondary/tertiary care medical institutions.11 The reason is that hospitals struggling with COVID-19 can be associated with poorer outcomes for other diseases12–15 due to both COVID-19-specific factors and indirect factors.13 On the other hand, increasing admission of patients with COVID-19 might suppress the hospitalisation due to other diseases especially, mild to moderate illnesses such as admissions for ACSCs. Although a study in one state in the USA reported that the number of admissions for ACSCs decreased during the pandemic,16 there is no nationwide study, especially in Asia, examining the association between admission for ACSCs and COVID-19 infection. We hypothesised that the COVID-19 pandemic has increased admissions for ACSCs in epidemic areas due to primary care physicians’ focus on patients with COVID-19 and patients’ refraining from medical care.

This study aimed to examine: (1) How the total number of admissions for ACSCs has changed between the areas with higher and lower rates of COVID-19 infection and (2) How the number of admissions for acute ACSCs, chronic ACSCs and vaccine-preventable ACSCs has changed in Japan.

The results of the study would be useful to better understand how the COVID-19 pandemic has affected primary and secondary care in terms of ACSCs. In addition, describing admissions for ACSCs is important as basic information for analysing role-sharing between primary and secondary care during the pandemic.

Methods

Design

We conducted a retrospective, two-stage, cross-sectional study.

Setting

We extracted data from the nationwide Japanese Diagnosis Procedure Combination (DPC) inpatient database17 18 from March 2019 to September 2019 and the same period in 2020.

Participants

Inclusion criteria

All patients aged ≥20 years who were admitted due to ACSCs during the study period were eligible for inclusion. We only included the same hospitals in 2019 and 2020. There were no exclusion criteria in this study.

Data source

The DPC contains data from 7 million inpatients admitted to 1173 hospitals in 2019, which represents 50% of all discharges from acute care hospitals in Japan.19 Hospital data were extracted from the Survey of Medical Institutions data in Japan.19 The data include the main problems for admission, age, sex, postal code of a patient, procedures and treatment during hospitalisation, and length of stay. In this study, university hospitals and hospitals in the National Hospital Organisation were not included because they did not submit data at the time of data extraction. The organisation includes 140 hospitals and 52 600 beds in Japan.20 The hospitals in the organisation mainly consist of tertiary medical centres.20

Data collection tools and procedures

The data included age, sex, diagnosis codes according to the International Classification of Diseases 10th Revision (ICD-10) and the Charlson Comorbidity Index (CCI),21 and length of stay. We defined the period between March 2019 and September 2019 as before the COVID-19 pandemic and between March 2020 and September 2020 as after the start of the COVID-19 pandemic.

A main predictor of the study is ‘the state of emergency’ or not. This is an indicator of the areas with higher infection rates. In Japan, the declaration of the state of emergency is decided by the prime minister based on the bed occupancy rate for patients with COVID-19, the number of patients per 100 000 people, the number of new patients, etc, in each prefecture.22 Under the state of emergency, people are requested to refrain from going out and travelling unnecessarily, avoid social gathering and to reduce commuting by telecommuting.22 Also, restaurants that serve alcoholic beverages or have karaoke are asked to cooperate with closure requests and all other restaurants are requested to cooperate in closing by 20:00 hours.22

The Japanese government declared a state of emergency on 7 April 2020, for seven prefectures (Saitama, Chiba, Tokyo, Kanagawa, Osaka, Hyogo and Fukuoka), and the local government of the Hokkaido prefecture, the northern part of Japan, proclaimed the same on 28 February 2020. Although the Japanese government adopted measures for the entire country of Japan from 16 April, eight prefectures remained at the centre of the pandemic. Of the 47 prefectures in Japan, the patients in the eight prefectures accounted for 72.5% of the total number of COVID-19 patients. We described the number of COVID-19 patients per 100 000 people in prefectures with the state of emergency and without the state of emergency in figure 1. Therefore, we compared data from these eight prefectures with those from other prefectures. The declaration of the state of emergency might be effective in reducing the reproduction number by requesting individuals to refrain from going out.23

Figure 1

Number of COVID-19 patients per 100 000 people in prefectures with the state of emergency and without the state of emergency.

Measures

The outcomes of this study were the numbers of the following four types of ACSCs per 100 000 people between the COVID-19 the areas with higher and lower rates of COVID-19 infection: (1) acute ACSCs (where early appropriate intervention can prevent more serious progression, eg, dehydration and gastroenteritis); (2) chronic ACSCs (where effective outpatient care can prevent exacerbation, eg, asthma, congestive heart failure and diabetes complications)(3) preventable ACSCs (where vaccination and other interventions can prevent illness, eg, influenza and pneumococcal pneumonia: the category does not include COVID-19)24 and (4) overall ACSCs (a composite of these three ACSCs). Table 1 lists the ICD-10 codes for the three ACSCs. Changes in the number of admissions for ACSCs in each month are described. In this study, we employed 19 ACSCs commonly used in the National Health Service in the UK.24 The study excluded patients with COVID-19 from the number of admissions for ACSCs. We employed the population in Japan and each prefecture as of 1 October 2019 and 2020 due to data availability.25

Table 1

ACSCs in this study: based on the National health service in the UK

Baseline data

We described age, sex, length of hospital stay and CCI of the patients admitted during the study period due to ACSCs.19 21 We selected these variables based on the previous literature.19 26

Statistical analysis

Continuous variables were presented as mean, SD, median and IQR. Categorical variables were presented as numbers and percentages. We employed a difference-in-differences design to compare the number of hospital admissions due to ACSCs between March 2019 and September 2019 (prepandemic) and March 2020 and September 2020 (during the pandemic).19 26 27 As mentioned above, we compared prefectures under the state of emergency with prefectures not under the state of emergency. Also, as a subgroup analysis, we conducted a difference-in-difference analysis to compare the number of admissions for ACSCs each month in 2019 and 2020. All statistical analyses were conducted using StataCorp. 2017. Stata Statistical Software: Release 15., StataCorp. We conducted a difference-in-difference analysis by creating an interaction between time (2019 and 2020) and exposure (the state of emergency).28

Results

The total number of ACSC admissions was 464 560 (276 530 in 2019 and 188 030 in 2020). Of the total number of admissions for ACSCs, the number of acute ACSCs was 143 074 (83 196 in 2019 and 59 878 in 2020), chronic ACSC admissions were 262 596 (153 495 in 2019 and 109 101 in 2020) and vaccine preventable ACSC admissions were 58 890 (39 839 in 2019 and 19 051 in 2020). In 2020, 74 959 ACSC admissions occurred in prefectures under the declared state of emergency. The total number of admissions for COVID-19 was 19 173 (male/female:11 128/8045) and the median age was 59 (IQR 39–78) years. Table 2 shows the characteristics of the participants.

Table 2

Characteristics of a cumulative total of the patients who were admitted due to ambulatory care sensitive conditions before and during COVID-19 pandemic in the prefectures declared a state of emergency and other areas

Table 3 describes the changes in the number of ACSC admissions per 100 000 people before and during the COVID-19 pandemic. In prefectures under the state of emergency, the change in the number of admissions for ACSCs was not statistically significant: 7.50 (95% CI −87.02 to 102.01, p=0.873). Regarding acute, chronic and preventable ACSCs, the differences in the number of admissions were not significant: 2.57 (95% CI −38.54 to 43.69, p=0.901), 0.56 (95% CI −47.73 to 48.85, p=0.982), and 4.14 (95% CI −113.09 to 21.37), respectively.

Table 3

Difference-in-differences analyses for changes in admissions for ambulatory care sensitive conditions (ACSCs) per 100 000 people in the prefectures declared a state of emergency and other areas

Figure 2A−D shows the change in the number of admissions for ACSCs each month from March to September in 2019 and 2020.

Figure 2

(A) Difference-in-differences analyses for changes in admissions for all ambulatory care sensitive conditions (ACSCs) per 100 000 people each month in the prefectures declared a state of emergency and other areas. (B) Difference-in-differences analyses for changes in admissions for acute ACSCs per 100 000 people each month in the prefectures declared a state of emergency and other areas. (C) Difference-in-differences analyses for changes in admissions for chronic ACSCs per 100 000 people each month in the prefectures declared a state of emergency and other areas. (D): Difference-in-differences analyses for changes in admissions for preventable ACSCs per 100 000 people each month in the prefectures declared a state of emergency and other areas.

Discussion

This is a nationwide survey that describes admissions for ACSCs. A reduction in admissions for ACSCs due to the COVID-19 pandemic was not statistically significant between the areas with higher and lower rates of COVID-19 infection .

The results differed from our hypotheses. A possible reason may be the changes in individual lifestyle habits in both the areas with higher and lower rates of COVID-19 infection, such as wearing masks or washing hands, which can reduce or limit the number of acute and preventable ACSCs. In Japan, admissions for asthma also decreased, and one mechanism responsible for this change was the adoption of these personal level hygiene measures.29 In addition, ‘staying home’ to avoid contacting people affected by COVID-1929 30 could be associated with a lack of significant changes in admissions for ACSCs all over Japan. Regarding preventable ACSCs, admission for influenza decreased in 2020 in Japan.31 This could be associated with a reduction in preventable ACSCs in Japan. Second, regarding chronic ACSCs, a healthy lifestyle, even during the stay-home period, may have contributed to preventing an increase in the number of ACSC admissions. A small study in Japan reported that patients with diabetes had maintained or improved their dietary habits.32 In addition, patients might have avoided visiting hospitals to reduce the burden on medical institutions or to avoid contact with people with COVID-195 30 and thus might have implemented self-care. These changes might have occurred in both the areas with higher and lower rates of COVID-19 infection. Third, the Japanese government has provided hotels to non-critical patients with COVID-19 to prevent surges in hospital admissions.30 This strategy might have been helpful in maintaining the quality of care in small-sized to medium-sized hospitals. Fourth, the impact of the pandemic on ACSC admissions might take a longer time. Thus, we must continuously evaluate the number of admissions for ACSCs.

The clinical implications of the study are that COVID-19 affects not only the areas with higher infection rates but also the areas with lower rates. Previous research has reported reductions in non-ACSC and ACSC hospitalisations during the COVID-19 pandemic. In addition, this study demonstrated that COVID-19 might influence healthcare use, even in the areas with lower infection rates. These results might be affected by multiple factors, such as changes in individual lifestyle, healthcare-seeking behaviour and health policy. In the areas with higher and lower rates of COVID-19 infection, primary care providers need to adjust to the change in healthcare use.

To the best of our knowledge, this is the first nationwide study to describe the impact of COVID-19 on ACSCs in the areas with higher and lower rates of COVID-19 infection. This study demonstrated the comprehensive status of ACSCs during the COVID-19 pandemic.

This study had some limitations. First, the definition of ACSCs in the study was developed in the UK24 and its validity in Japan remains unclear.19 There is currently no Japanese definition of ACSCs. As previous studies in Japan have employed the UK definition,19 24 33 we used the same definition in this study. Second, this study did not include information on the socioeconomic status of patients, as admissions for ACSCs have been associated with lower socioeconomic status.8 Since our dataset did not contain this information, our results need to be interpreted carefully. In addition, the lack of difference in admissions for ACSCs might be explained by the fear of exposure from going to the hospital.34 To overcome this limitation, we need to consider the number of out-of-hospital mortalities due to ACSCs. However, there is no database to count the number of ACSCs in out-of-hospital settings in Japan. Lastly, because the study did not include university hospitals and hospitals of the National Hospital Organisation, we could not determine the status of admissions for ACSCs in these hospitals. The status in these tertiary care hospitals might change differently compared with community hospitals.

Conclusion

This study revealed the number of hospital admissions for total and acute/chronic/preventable ACSCs before and during the COVID-19 pandemic in Japan. Although admissions for ACSCs decreased during the COVID-19 pandemic, there was no significant change between the areas with higher and lower rates of COVID-19 infection. This implies that the COVID-19 pandemic affects the areas with higher infection rates and the areas with lower rates. Individual lifestyle habits, a patient’s healthcare-seeking behaviour, and health policies may affect the results.

Data availability statement

Data are available on reasonable request. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ethics statements

Patient consent for publication

Ethics approval

The study protocol was performed in accordance with the Declaration of Helsinki, reviewed and approved by the ethics committee of the Tokyo Medical and Dental University (approval number: M2000-78-16). Informed consent was waived by the ethics committee of the Tokyo Medical and Dental University due to the anonymous nature of the data.

Acknowledgments

We would like to thank Editage (www.editage.com) for English language editing.

References

Footnotes

  • Twitter @makoto_knk

  • Contributors MK designed the study and participated in the implementation, data collection, data analysis, and writing of the manuscript. MK also served as the guarantor. SS, AO and KF contributed to the design of the study and critically reviewed the manuscript. MK analysed the data. All authors had full access to the data and take responsibility for the integrity and accuracy of the analyses and all authors have read and approved the manuscript.

  • Funding This study was supported by a grant from the 2020–2021 Research Development Fund of Yokohama City University.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.